[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1930 Introduced in House (IH)]

113th CONGRESS
  1st Session
                                H. R. 1930

To prohibit the manufacture, marketing, sale, or shipment in interstate 
   commerce of products designed to assist in defrauding a drug test.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 9, 2013

 Mr. Engel (for himself and Mr. Terry) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To prohibit the manufacture, marketing, sale, or shipment in interstate 
   commerce of products designed to assist in defrauding a drug test.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Drug Testing Integrity Act of 
2013''.

SEC. 2. BAN OF PRODUCTS DESIGNED TO DEFRAUD DRUG TESTS.

    (a) Conduct Prohibited.--It shall be unlawful to knowingly 
manufacture, market, sell, ship, or otherwise provide to another 
individual any product with the intent to assist such other individual 
to use such product to defraud a drug test.
    (b) Definition.--As used in this Act, the term ``defraud a drug 
test'' means--
            (1) submit a substance that purports to be from an 
        individual other than its actual source, or purports to have 
        been excreted or collected other than when it was actually 
        excreted or collected; or
            (2) engage in any other conduct with the intent to produce 
        a false or misleading outcome of a test for the presence of a 
        controlled substance.

SEC. 3. ENFORCEMENT BY THE FEDERAL TRADE COMMISSION.

    (a) Unfair and Deceptive Act or Practice.--A violation of section 2 
shall be treated as a violation of a rule defining an unfair or 
deceptive act or practice prescribed under section 18(a)(1)(B) of the 
Federal Trade Commission Act (15 U.S.C. 57a(a)(1)(B)).
    (b) Enforcement Authority.--The Federal Trade Commission shall 
enforce this Act in the same manner, by the same means, and with the 
same jurisdiction as though all applicable terms and provisions of the 
Federal Trade Commission Act were incorporated into and made a part of 
this Act.
                                 <all>